1h Free Analyst Time
The influenza diagnostics market is forecasted to grow by USD 466.18 mn during 2022-2027, accelerating at a CAGR of 6.95% during the forecast period. The report on the influenza diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising incidence of influenza, growing demand for molecular diagnostics, and supportive government initiatives and funding.
The influenza diagnostics market is segmented as below:
By End-user
- Hospitals and diagnostic laboratories
- Academic and research centers
- Homecare
By Type
- Point-of-care testing
- Immunodiagnostics
- Molecular diagnostics
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the influenza diagnostics market covers the following areas:
- Influenza diagnostics market sizing
- Influenza diagnostics market forecast
- Influenza diagnostics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global influenza diagnostics market: Abbott Laboratories, Becton Dickinson and Co., BICO Group AB, Bio Rad Laboratories Inc., Biocartis Group NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Princeton BioMeditech Corp., QIAGEN NV, Response Biomedical Corp., SA Scientific Ltd., Sd Biosensor Inc., Sekisui Chemical Co. Ltd., Siemens Healthineers AG, Tecan Trading AG, Thermo Fisher Scientific Inc., and Quidelortho Corp..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising approvals for influenza diagnostic products.'
According to the report, one of the major drivers for this market is the rising incidence of influenza.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Becton Dickinson and Co.
- BICO Group AB
- Bio Rad Laboratories Inc.
- Biocartis Group NV
- bioMerieux SA
- Danaher Corp.
- DiaSorin SpA
- F. Hoffmann La Roche Ltd.
- Hologic Inc.
- Princeton BioMeditech Corp.
- QIAGEN NV
- Response Biomedical Corp.
- SA Scientific Ltd.
- Sd Biosensor Inc.
- Sekisui Chemical Co. Ltd.
- Siemens Healthineers AG
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- Quidelortho Corp.